Trials, publications and grants since Nov 2024.
Publication
Optical genome mapping reveals a MYC-amplified ring chromosome arising through chromoanagenesis in AML.
Blood, Oct 2026
Publication
Daratumumab ± pomalidomide maintenance after salvage autologous transplantation in relapsed multiple myeloma: a phase 2 study.
Blood cancer journal, Sept 2026
Publication
Prognostic impact of monosomy 13 and deletion of 13q in multiple myeloma patients undergoing upfront autologous transplantation.
British journal of haematology, Jul 2026
Publication
Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) induction prior to autologous haematopoietic stem cell transplant/transplantation in newly diagnosed multiple myeloma.
British journal of haematology, Jul 2026
Publication
Integrated Analysis of Genomics, Molecular Responses, and Outcomes of CBF-AML with FLAG-Based Therapy on a Phase II Trial.
Blood cancer discovery, Jul 2026
Publication
Optical genome mapping in myeloid neoplasms.
Human pathology, May 2026
Publication
Prognostic impact of ASXL1 mutations in acute myeloid leukemia treated with lower intensity therapy.
Cancer, May 2026
Publication
Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.
Blood cancer discovery, May 2026
Publication
Immunophenotypic changes following menin inhibition in acute myeloid leukemia.
Leukemia, Mar 2026
Publication
Comprehensive Cytogenomic Profiling of T-Lymphoblastic Leukemia Using Optical Genome Mapping, Karyotyping, and Next-Generation Sequencing.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Mar 2026
Publication
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies.
HemaSphere, Feb 2026
Publication
Acute leukemia with BCL11B rearrangements: Genetic landscape, BCL11B expression, and therapeutic response.
Human pathology, Jan 2026
Publication
Persistent monosomy 7 in Philadelphia chromosome-negative cells without disease progression over nearly two decades of follow-up in chronic myeloid leukemia.
Cancer genetics, Jan 2026
Publication
Aberrant CD25 and Increased CD123 Expression Are Common in Acute Myeloid Leukemia with KMT2A Partial Tandem Duplication and Are Associated with FLT3 Internal Tandem Duplication.
Cancers, Jan 2026
Publication
Optical Genome Mapping for Cytogenetic Analysis in Multiple Myeloma: Real-World Evidence.
American journal of hematology, Jan 2026
Publication
Lowering the Diagnostic Threshold in Secondary Plasma Cell Leukemia? Comparison With Primary Cases and Implications for Flow Cytometry Immunophenotyping.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Dec 2025
Publication
Post-transplant outcomes in IgD multiple myeloma:a propensity score-matched analysis.
Transplantation and cellular therapy, Dec 2025
Publication
Results of delayed or salvage autologous hematopoietic stem cell transplantation for multiple myeloma.
Bone marrow transplantation, Dec 2025
Publication
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias.
Journal of hematology & oncology, Nov 2025
Publication
Acute myeloid leukemia with t(10;17)(p15;q21)/ ZMYND11::MBTD1: a subtype with minimal differentiation, CD7/CD56 expression, and generally poor outcomes in adults.
Haematologica, Nov 2025
Publication
Mixed-Phenotype Acute Leukemia With Mutated TP53: Genetic Landscape, Therapeutic Response, and Outcomes.
American journal of hematology, Nov 2025
Publication
Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute Leukemia.
Cancers, Oct 2025
Publication
Optical Genome Mapping in Myelodysplastic Syndromes: Clinical Value and Limitations Derived From a Cohort of 236 Patients.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, Aug 2025
Publication
Erythroid-predominant myelodysplastic neoplasms exhibit a distinct genomic landscape with poor outcomes after venetoclax-based therapy.
Leukemia, Jul 2025
Publication
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative Analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research, Jun 2025
Publication
Trisomy 8 in De Novo Acute Myeloid Leukemia Lacking MDS-Related Cytogenetics Does Not Significantly Influence Survival.
International journal of laboratory hematology, May 2025
Publication
Novel Recurrent Cytogenetic Abnormalities Predict Overall Survival in Tetraploid/Near-Tetraploid Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Cancers, Apr 2025